Sex: U
Vaccine: PNC20, TDAP, UNK
Symptoms: Skin warm
Clinical narrative: "I had, obviously discomfort at the injection site; injection site red; i developed rash running down my arm to the injection site to the elbow; it did not feel well; my arm remained very warm to the touch; I also had headache; arm red; This non-serious case was reported by a consumer via other manufacturer and described the occurrence of injection site discomfort in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number T3Z7D) for prophylaxis.   Co-suspect products included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20) (batch number HL3888, expiry date 30-JUN-2025) for prophylaxis and cefalexin sodium (Cephalexin) for product used for unknown indication.   Concomitant products included meloxicam and hydroxychloroquine sulfate (Hydroxychloroquine).   On 24-APR-2024, the patient received Boostrix (intramuscular, right arm) and Prevnar 20. On an unknown date, the patient started Cephalexin 500 mg. On an unknown date, an unknown time after receiving Boostrix, the patient experienced injection site discomfort (Verbatim: "I had, obviously discomfort at the injection site), injection site erythema (Verbatim: injection site red), rash (Verbatim: i developed rash running down my arm to the injection site to the elbow), feeling unwell (Verbatim: it did not feel well), skin warm (Verbatim: my arm remained very warm to the touch), headache (Verbatim: I also had headache) and erythema of extremities (Verbatim: arm red). The patient was treated with paracetamol (Tylenol). The action taken with Cephalexin was unknown. The outcome of the injection site discomfort, injection site erythema, skin warm and erythema of extremities were not resolved and the outcome of the rash and headache were not reported and the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the injection site discomfort, injection site erythema, rash, feeling unwell, skin warm, headache and erythema of extremities to be related to Boostrix.     It was unknown if the company considered the injection site discomfort, injection site erythema, rash, feeling unwell, skin warm, headache and erythema of extremities to be related to Boostrix.   Additional Information: GSK Receipt Date: 07-MAY-2024 The patient had discomfort at the injection site which lingered because of vaccine on the same day. The injection site was red and uncomfortable initially but that feeling lingered and then a week after, developed rash running down arm to the injection site to the elbow and it did not feel well.  The patient went to an urgent care facility to see a physician, and he decided it would be prudent to put on antibiotic just because of concerns about possible infections. The patient started antibiotic and then three days after that arm, during all this time, arm remained very warm to the touch, three days after started the antibiotic, in the evening, one evening again, it started getting warm again, it was uncomfortable and it was red and, so the patient still on antibiotic.  At the time of reporting, the patient woke up and arm was not normal again. The patient still has adverse reaction after taking the antibiotic.  When the patient started the antibiotics initially the redness subsided and then it reappeared, three days after was on that. It stayed red until went to get on antibiotic, got on antibiotic, the redness had subsided, and in three days later, the redness reappeared.